199 related articles for article (PubMed ID: 25193855)
1. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
[TBL] [Abstract][Full Text] [Related]
2. A novel p70 S6 kinase-microRNA biogenesis axis mediates multicellular spheroid formation in ovarian cancer progression.
Lam SS; Ip CK; Mak AS; Wong AS
Oncotarget; 2016 Jun; 7(25):38064-38077. PubMed ID: 27191261
[TBL] [Abstract][Full Text] [Related]
3. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
Matte I; Legault CM; Garde-Granger P; Laplante C; Bessette P; Rancourt C; Piché A
Clin Exp Metastasis; 2016 Dec; 33(8):839-852. PubMed ID: 27612856
[TBL] [Abstract][Full Text] [Related]
4. Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion.
Cheung LW; Yung S; Chan TM; Leung PC; Wong AS
Mol Ther; 2013 Jan; 21(1):78-90. PubMed ID: 23164934
[TBL] [Abstract][Full Text] [Related]
5. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target.
Sawada K; Mitra AK; Radjabi AR; Bhaskar V; Kistner EO; Tretiakova M; Jagadeeswaran S; Montag A; Becker A; Kenny HA; Peter ME; Ramakrishnan V; Yamada SD; Lengyel E
Cancer Res; 2008 Apr; 68(7):2329-39. PubMed ID: 18381440
[TBL] [Abstract][Full Text] [Related]
6. The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.
Schultz MJ; Holdbrooks AT; Chakraborty A; Grizzle WE; Landen CN; Buchsbaum DJ; Conner MG; Arend RC; Yoon KJ; Klug CA; Bullard DC; Kesterson RA; Oliver PG; O'Connor AK; Yoder BK; Bellis SL
Cancer Res; 2016 Jul; 76(13):3978-88. PubMed ID: 27216178
[TBL] [Abstract][Full Text] [Related]
7. A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread.
Loessner D; Rizzi SC; Stok KS; Fuehrmann T; Hollier B; Magdolen V; Hutmacher DW; Clements JA
Biomaterials; 2013 Oct; 34(30):7389-400. PubMed ID: 23827191
[TBL] [Abstract][Full Text] [Related]
8. Activation of integrin β1 mediates the increased malignant potential of ovarian cancer cells exerted by inflammatory cytokines.
Yang Z; Zhou X; Liu Y; Gong C; Wei X; Zhang T; Ma D; Gao Q
Anticancer Agents Med Chem; 2014; 14(7):955-62. PubMed ID: 24931361
[TBL] [Abstract][Full Text] [Related]
9. p70 S6 kinase promotes epithelial to mesenchymal transition through snail induction in ovarian cancer cells.
Pon YL; Zhou HY; Cheung AN; Ngan HY; Wong AS
Cancer Res; 2008 Aug; 68(16):6524-32. PubMed ID: 18701475
[TBL] [Abstract][Full Text] [Related]
10. Interactions of human peritoneal mesothelial cells with serous ovarian cancer cell spheroids--evidence for a mechanical and paracrine barrier function of the peritoneal mesothelium.
Stadlmann S; Feichtinger H; Mikuz G; Marth C; Zeimet AG; Herold M; Knabbe C; Offner FA
Int J Gynecol Cancer; 2014 Feb; 24(2):192-200. PubMed ID: 24407573
[TBL] [Abstract][Full Text] [Related]
11. P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin.
Cheung LW; Mak AS; Cheung AN; Ngan HY; Leung PC; Wong AS
Oncogene; 2011 Jun; 30(26):2964-74. PubMed ID: 21317933
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium.
Iwanicki MP; Davidowitz RA; Ng MR; Besser A; Muranen T; Merritt M; Danuser G; Ince TA; Brugge JS
Cancer Discov; 2011 Jul; 1(2):144-57. PubMed ID: 22303516
[TBL] [Abstract][Full Text] [Related]
13. Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids.
Desjardins M; Xie J; Gurler H; Muralidhar GG; Sacks JD; Burdette JE; Barbolina MV
J Ovarian Res; 2014; 7():70. PubMed ID: 24999371
[TBL] [Abstract][Full Text] [Related]
14. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
[TBL] [Abstract][Full Text] [Related]
15. Wnt11 alters integrin and cadherin expression by ovarian cancer spheroids and inhibits tumorigenesis and metastasis.
Azimian-Zavareh V; Hossein G; Ebrahimi M; Dehghani-Ghobadi Z
Exp Cell Res; 2018 Aug; 369(1):90-104. PubMed ID: 29753625
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal adhesion and angiogenesis in ovarian carcinoma are inversely regulated by hyaluronan: the role of gonadotropins.
Tzuman YC; Sapoznik S; Granot D; Nevo N; Neeman M
Neoplasia; 2010 Jan; 12(1):51-60. PubMed ID: 20072653
[TBL] [Abstract][Full Text] [Related]
17. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.
Torchiaro E; Lorenzato A; Olivero M; Valdembri D; Gagliardi PA; Gai M; Erriquez J; Serini G; Di Renzo MF
Oncotarget; 2016 Jan; 7(1):712-28. PubMed ID: 26625210
[TBL] [Abstract][Full Text] [Related]
19. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids.
Casey RC; Burleson KM; Skubitz KM; Pambuccian SE; Oegema TR; Ruff LE; Skubitz AP
Am J Pathol; 2001 Dec; 159(6):2071-80. PubMed ID: 11733357
[TBL] [Abstract][Full Text] [Related]
20. Elevated CDCP1 predicts poor patient outcome and mediates ovarian clear cell carcinoma by promoting tumor spheroid formation, cell migration and chemoresistance.
He Y; Wu AC; Harrington BS; Davies CM; Wallace SJ; Adams MN; Palmer JS; Roche DK; Hollier BG; Westbrook TF; Hamidi H; Konecny GE; Winterhoff B; Chetty NP; Crandon AJ; Oliveira NB; Shannon CM; Tinker AV; Gilks CB; Coward JI; Lumley JW; Perrin LC; Armes JE; Hooper JD
Oncogene; 2016 Jan; 35(4):468-78. PubMed ID: 25893298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
